SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-22-002783
Filing Date
2022-11-15
Accepted
2022-11-15 13:44:58
Documents
85
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A axim_10qa.htm   iXBRL 10-Q/A 1614766
2 CERTIFICATION axim_ex311.htm EX-31.1 13600
3 CERTIFICATION axim_ex312.htm EX-31.2 13630
4 CERTIFICATION axim_ex321.htm EX-32.1 4309
5 CERTIFICATION axim_ex322.htm EX-32.2 4229
11 axim_10qimg1.jpg GRAPHIC 4952
  Complete submission text file 0001096906-22-002783.txt   7615361

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20220930.xsd EX-101.SCH 95479
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20220930_lab.xml EX-101.LAB 489074
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20220930_cal.xml EX-101.CAL 66370
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20220930_pre.xml EX-101.PRE 404061
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20220930_def.xml EX-101.DEF 235727
79 EXTRACTED XBRL INSTANCE DOCUMENT axim_10qa_htm.xml XML 965832
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 221390441
SIC: 2834 Pharmaceutical Preparations